Affiliation:
1. Department of Psychology University of Jaén Jaén Spain
2. Department of Psychology and Anthropology University of Extremadura, Avenida de la Universidad Cáceres Spain
3. Department of Psychology Institute of Hematology and Immunology Havana Cuba
Abstract
AbstractBackgroundResponses to experimental pain have suggested central and peripheral sensitisation in adult patients with sickle cell disease (SCD). Recent studies have proposed an algometry‐derived dynamic measure of pain sensitisation, slowly repeated evoked pain (SREP), which is useful in the discrimination of painful conditions related to central sensitisation. Pain and fatigue are two symptoms that affect the general functioning of patients with SCD most significantly, however, research about experimental dynamic pain measures and their relation to the main symptoms of SCD (pain and fatigue) is still scarce.ObjectiveThis preliminary study aimed to test the utility of the SREP protocol for detecting pain sensitisation in patients with SCD, and to evaluate the associations of pain sensitisation, pain threshold, and pain tolerance with the main clinical symptoms of SCD, pain and fatigue.MethodsTwenty‐two female outpatients with SCD and 20 healthy women participated. Pain threshold, pain tolerance, and pain sensitisation were assessed by algometry in the fingernail. Clinical pain, fatigue, anxiety, depression and pain catastrophizing were evaluated.ResultsNo group differences were found in pain threshold and tolerance. However, using the SREP protocol, pain sensitisation was greater in patients than in healthy participants, even after controlling for psychological variables and body mass index. Pain threshold and tolerance were inversely associated with fatigue levels in the SCD group, with pain tolerance being the main predictor.ConclusionsPain threshold and tolerance did not discriminate between patients and healthy individuals, but were useful for predicting fatigue severity in SCD. The SREP protocol provides a useful dynamic measure of pain for the discrimination and detection of enhanced pain sensitisation in patients with SCD, which could contribute to more personalised pain evaluations and treatment for these patients.
Reference41 articles.
1. Sickle cell disease: old discoveries, new concepts, and future promise;Frenette PS;J Clin Invest,2007
2. National Heart Lung Blood Institute (NHLBI). Evidence based management of sickle cell disease: Expert panel report. Bethesda MD: U.S. Department of Health and Human Services.2014.
3. The natural history of sickle cell disease;Serjeant GR;Cold Spring Harbor Perspect Med,2013
4. Impacto del programa de prevención de anemia por hematíes falciformes en Cuba: 1982‐2016;Marcheco‐Teruel B;An Acad Cien Cuba,2018